Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2020
Reporting Period: Event date of May 12, 2020
The filing reports an unregistered sale of equity securities pursuant to a pre-existing agreement with MacAndrews & Forbes Group LLC.
Key Financial Metrics
This filing does not contain comprehensive financial statements (revenue, profit, cash flow, or margins). The specific financial activity reported is:
- Capital Raised: $1.0 million
- Shares Issued: 625,000 shares of Class A common stock
- Price Per Share: $1.60
- Investor: MacAndrews & Forbes Group LLC
Debt, liquidity, and operating metrics are not disclosed in this document.
Material Changes
The material change reported is the execution of a capital raise under the "December 2019 Letter Agreement." The Company exercised its right to require the Investor to purchase the shares, resulting in an immediate increase in cash assets and an increase in outstanding Class A common stock.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the transaction was executed following the signing of definitive documentation. It references the December 2019 Letter Agreement (Exhibit 10.25 to the 2020 Form 10-K) for full terms and conditions.
Risks and Contingencies: No new risks or contingencies are detailed in this specific 8-K filing beyond the standard disclosure of the equity sale.
Investor Verification Checklist
- Verify the terms of the December 2019 Letter Agreement referenced in the filing.
- Confirm the total number of outstanding shares post-transaction to assess dilution impact.
- Review the Company's most recent Form 10-K or 10-Q for current cash position and burn rate to understand the utility of the $1.0 million raise.
- Check for any subsequent filings regarding the use of proceeds from this transaction.